欧洲甲型H1N1流感病毒对奥司他韦耐药性的出现。 - Suppr

Suppr

超能文献

Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe.

作者信息

Lackenby A, Hungnes O, Dudman S G, Meijer A, Paget W J, Hay A J, Zambon M C

机构信息

Health Protection Agency, Centre for Infection, London, United Kingdom.

出版信息

Euro Surveill. 2008 Jan 31;13(5):8026. doi: 10.2807/ese.13.05.08026-en.

DOI:10.2807/ese.13.05.08026-en

PMID:18445375

Abstract

摘要

相似文献

Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe.

Euro Surveill. 2008 Jan 31;13(5):8026. doi: 10.2807/ese.13.05.08026-en.

Oseltamivir- and amantadine-resistant influenza viruses A (H1N1).

Emerg Infect Dis. 2009 Jun;15(6):966-8. doi: 10.3201/eid1506.081357.

Delayed emergence of oseltamivir-resistant seasonal influenza A (H1N1) and pandemic influenza A(H1N1)pdm09 viruses in Myanmar.

Influenza Other Respir Viruses. 2013 Sep;7(5):766-71. doi: 10.1111/irv.12030. Epub 2012 Nov 5.

Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa.

Antiviral Res. 2009 Jul;83(1):90-3. doi: 10.1016/j.antiviral.2009.03.003. Epub 2009 Mar 24.

Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08.

Emerg Infect Dis. 2009 Feb;15(2):155-62. doi: 10.3201/eid1502.081031.

Monitoring influenza virus susceptibility to oseltamivir using a new rapid assay, iART.

Euro Surveill. 2017 May 4;22(18). doi: 10.2807/1560-7917.ES.2017.22.18.30529.

Pandemic influenza A(H1N1)v viruses currently circulating in New Zealand are sensitive to oseltamivir.

Euro Surveill. 2009 Jul 30;14(30):19282. doi: 10.2807/ese.14.30.19282-en.

Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.

J Clin Virol. 2010 Jan;47(1):23-8. doi: 10.1016/j.jcv.2009.11.003. Epub 2009 Dec 3.

Observed oseltamivir resistance in seasonal influenza viruses in Europe interpretation and potential implications.

Euro Surveill. 2008 Jan 31;13(5):8025. doi: 10.2807/ese.13.05.08025-en.

Characteristics of oseltamivir-resistant influenza A (H1N1) pdm09 virus during the 2013-2014 influenza season in Mainland China.

Virol J. 2015 Jun 24;12:96. doi: 10.1186/s12985-015-0317-1.

引用本文的文献

Impact of the H274Y Substitution on N1, N4, N5, and N8 Neuraminidase Enzymatic Properties and Expression in Reverse Genetic Influenza A Viruses.

Viruses. 2024 Mar 1;16(3):388. doi: 10.3390/v16030388.

Molecular Determinants of Drug Resistance and Mutation Patterns in Influenza Viruses Circulating in Poland Across Multiple Epidemic Seasons: Implications for Vaccination Strategies.

Med Sci Monit. 2024 Mar 6;30:e942125. doi: 10.12659/MSM.942125.

Potential Impact of Environmental Pollution by Human Antivirals on Avian Influenza Virus Evolution.

Animals (Basel). 2023 Mar 23;13(7):1127. doi: 10.3390/ani13071127.

A systemic review on medicinal plants and their bioactive constituents against avian influenza and further confirmation through analysis.

Heliyon. 2023 Mar 10;9(3):e14386. doi: 10.1016/j.heliyon.2023.e14386. eCollection 2023 Mar.

Antiviral Effect of Ginsenosides rk1 against Influenza a Virus Infection by Targeting the Hemagglutinin 1-Mediated Virus Attachment.

Int J Mol Sci. 2023 Mar 4;24(5):4967. doi: 10.3390/ijms24054967.

Successful Treatment of Complicated Influenza A(H3N2) Virus Infection and Rhabdomyolysis with Compassionate Use of IV Zanamivir.

Pharmaceuticals (Basel). 2023 Jan 7;16(1):85. doi: 10.3390/ph16010085.

Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution.

J Virol. 2022 Aug 10;96(15):e0091822. doi: 10.1128/jvi.00918-22. Epub 2022 Jul 14.

Precision and Advanced Nano-Phytopharmaceuticals for Therapeutic Applications.

Nanomaterials (Basel). 2022 Jan 12;12(2):238. doi: 10.3390/nano12020238.

A study on catalytic and non-catalytic sites of H5N1 and H1N1 neuraminidase as the target for chalcone inhibitors.

Appl Biol Chem. 2021;64(1):69. doi: 10.1186/s13765-021-00639-w. Epub 2021 Sep 17.

Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group.

Antiviral Res. 2021 Oct;194:105158. doi: 10.1016/j.antiviral.2021.105158. Epub 2021 Aug 4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验